TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53

Overview of attention for article published in Drug Design, Development and Therapy, September 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Application EP-3319993-B1

European Patent Office